These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2139577)

  • 1. Evidence for allosteric variants of wild-type p53, a tumour suppressor protein.
    Cook A; Milner J
    Br J Cancer; 1990 Apr; 61(4):548-52. PubMed ID: 2139577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temperature-dependent switching between "wild-type" and "mutant" forms of p53-Val135.
    Milner J; Medcalf EA
    J Mol Biol; 1990 Dec; 216(3):481-4. PubMed ID: 2258922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form.
    Gannon JV; Greaves R; Iggo R; Lane DP
    EMBO J; 1990 May; 9(5):1595-602. PubMed ID: 1691710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
    Bartek J; Iggo R; Gannon J; Lane DP
    Oncogene; 1990 Jun; 5(6):893-9. PubMed ID: 1694291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the serine 312 phosphorylation site does not alter the ability of mouse p53 to inhibit simian virus 40 DNA replication in vivo.
    Meek DW; Eckhart W
    J Virol; 1990 Apr; 64(4):1734-44. PubMed ID: 2157055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of a potent transcription activating sequence in the p53 protein.
    Fields S; Jang SK
    Science; 1990 Aug; 249(4972):1046-9. PubMed ID: 2144363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of human colorectal carcinoma cell growth by wild-type p53.
    Baker SJ; Markowitz S; Fearon ER; Willson JK; Vogelstein B
    Science; 1990 Aug; 249(4971):912-5. PubMed ID: 2144057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A PAb240+ conformation of wild type p53 binds DNA.
    McLure KG; Lee PW
    Oncogene; 1996 Sep; 13(6):1297-303. PubMed ID: 8808704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line.
    Romano JW; Ehrhart JC; Duthu A; Kim CM; Appella E; May P
    Oncogene; 1989 Dec; 4(12):1483-8. PubMed ID: 2531855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'wildtype' conformation of p53: epitope mapping using hybrid proteins.
    Wang PL; Sait F; Winter G
    Oncogene; 2001 Apr; 20(18):2318-24. PubMed ID: 11402327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conformational change of a murine temperature-sensitive p53 protein is independent of a change in phosphorylation status.
    Picksley SM; Meek DW; Lane DP
    Oncogene; 1992 Aug; 7(8):1649-51. PubMed ID: 1630825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.
    Raycroft L; Wu HY; Lozano G
    Science; 1990 Aug; 249(4972):1049-51. PubMed ID: 2144364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Finlay CA; Hinds PW; Tan TH; Eliyahu D; Oren M; Levine AJ
    Mol Cell Biol; 1988 Feb; 8(2):531-9. PubMed ID: 2832726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
    Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evolution of the thermosensitive PAb1620 epitope of human p53 by DNA shuffling.
    Xirodimas DP; Lane DP
    J Biol Chem; 1999 Sep; 274(39):28042-9. PubMed ID: 10488156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutants of the tumour suppressor p53 L1 loop as second-site suppressors for restoring DNA binding to oncogenic p53 mutations: structural and biochemical insights.
    Merabet A; Houlleberghs H; Maclagan K; Akanho E; Bui TT; Pagano B; Drake AF; Fraternali F; Nikolova PV
    Biochem J; 2010 Mar; 427(2):225-36. PubMed ID: 20113312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition of fresh medium induces cell cycle and conformation changes in p53, a tumour suppressor protein.
    Milner J; Watson JV
    Oncogene; 1990 Nov; 5(11):1683-90. PubMed ID: 2176282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of p53 in primary, immortalised and transformed Balb/c mouse cells.
    Patschinsky T; Deppert W
    Oncogene; 1990 Jul; 5(7):1071-6. PubMed ID: 2142761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular tumour antigen p53: evidence for transformation-related, immunological variants of p53.
    Milner J; Cook A
    Virology; 1986 Oct; 154(1):21-30. PubMed ID: 2428168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics.
    Zhu YM; Bradbury D; Russell N
    Br J Cancer; 1993 Nov; 68(5):851-5. PubMed ID: 8217600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.